http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014019928-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_927c3131644244d81f82743c2a670aab
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22C38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C21D9-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22C38-38
filingDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60b5dcf107341130044a4cd65693e9ce
publicationDate 2014-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2014019928-A
titleOfInvention High strength cold rolled steel sheet and method for producing high strength cold rolled steel sheet
abstract A high-strength cold-rolled steel sheet having high ductility and excellent stretch flangeability is provided. A high-strength cold-rolled steel sheet has a component composition of mass%, C: 0.06% to 0.12%, Si: 0.4% to 0.8%, Mn: 1.6. %: 2.0% or less, Cr: 0.01% or more, 1.0% or less, V: 0.001% or more, 0.1% or less, P: 0.05% or less, S: 0.01% or less, Sol. Al: 0.01% or more and 0.5% or less, N: 0.005% or less, the balance is composed of iron and inevitable impurities, and the volume ratio of equiaxed ferrite in the metal structure is 50% The martensite volume fraction is 5% or more and 15% or less, the volume ratio of the retained austenite phase is 1% or more and 5% or less, the average particle size of the retained austenite phase is 10 μm or less, and the aspect ratio of the retained austenite phase Is 5 or less, and the remaining structure is composed of bainite and / or pearlite. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11618931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106133155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016194136-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018500455-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016143270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022513964-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017512904-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6004144-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954580-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020158228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11555226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287649-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10907232-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107406940-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718888-B2
priorityDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450380254

Total number of triples: 33.